InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $32.030 0.23 (0.72%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,941 Form 10-Q for the Quarter Ended December 31, 2025 2 Feb 2026 8:15AM $37.540 $32.030 fallen by 14.68%
$18,941 Dividend/Distribution - RMD 30 Jan 2026 8:27AM $36.400 $32.030 fallen by 12.01%
$18,941 Resmed Announces Results for the Second Quarter of FY2026 30 Jan 2026 8:26AM $36.400 $32.030 fallen by 12.01%
$18,941 4 Statement of changes in beneficial ownership 14 Jan 2026 8:20AM $38.500 $32.030 fallen by 16.81%
$18,941 4 Statement of changes in beneficial ownership 14 Jan 2026 8:20AM $38.500 $32.030 fallen by 16.81%
$18,941 Resmed to Report Second Quarter Fiscal 2026 Results 9 Jan 2026 8:29AM $37.100 $32.030 fallen by 13.67%
$18,941 144 Report of proposed sale of securities 9 Jan 2026 8:22AM $37.100 $32.030 fallen by 13.67%
$18,941 144 Report of proposed sale of securities 8 Jan 2026 12:46PM $37.060 $32.030 fallen by 13.57%
$18,941 4 Statement of changes in beneficial ownership 8 Jan 2026 12:23PM $37.050 $32.030 fallen by 13.55%
$18,941 4 Statement of changes in beneficial ownership 8 Jan 2026 12:21PM $37.050 $32.030 fallen by 13.55%
$18,941 Statement of CDIs on issue - RMD 6 Jan 2026 10:44AM $36.310 $32.030 fallen by 11.79%
$18,941 144 Report of proposed sale of securities 6 Jan 2026 8:20AM $36.490 $32.030 fallen by 12.22%
$18,941 144 Report of proposed sale of securities 6 Jan 2026 8:20AM $36.490 $32.030 fallen by 12.22%
$18,941 4 Statement of changes in beneficial ownership 10 Dec 2025 8:28AM $37.510 $32.030 fallen by 14.61%
$18,941 144 Report of proposed sale of securities 10 Dec 2025 8:26AM $37.510 $32.030 fallen by 14.61%
$18,941 4 Statement of changes in beneficial ownership 5 Dec 2025 8:25AM $37.810 $32.030 fallen by 15.29%
$18,941 144 Report of proposed sale of securities 5 Dec 2025 8:22AM $37.810 $32.030 fallen by 15.29%
$18,941 Statement of CDIs on issue - RMD 3 Dec 2025 11:07AM $38.080 $32.030 fallen by 15.89%
$18,941 144 Report of proposed sale of securities 3 Dec 2025 8:27AM $37.820 $32.030 fallen by 15.31%
$18,941 144 Report of proposed sale of securities 2 Dec 2025 8:22AM $37.500 $32.030 fallen by 14.59%
$18,941 4 Statement of changes in beneficial ownership 27 Nov 2025 8:25AM $39.310 $32.030 fallen by 18.52%
$18,941 4 Statement of changes in beneficial ownership 27 Nov 2025 8:24AM $39.310 $32.030 fallen by 18.52%
$18,941 144 Report of proposed sale of securities 26 Nov 2025 10:01AM $39.530 $32.030 fallen by 18.97%
$18,941 Ceasing to be a Director/Section 16 Officer 25 Nov 2025 12:27PM $38.510 $32.030 fallen by 16.83%
$18,941 4 Statement of changes in beneficial ownership 25 Nov 2025 12:19PM $38.560 $32.030 fallen by 16.93%

51 - 75 of 710 results

Page 3 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.